Skip to content

SAM-531

DRUG9 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

AdultAlzheimer DiseaseHealthy

Phase 1

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531
CompletedNCT00479349
Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease
Start: 2007-05-31End: 2008-01-31Target: 32Updated: 2009-07-07
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males
CompletedNCT00479297
Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease
Start: 2006-05-31End: 2007-02-28Target: 72Updated: 2009-08-07
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects
CompletedNCT00479700
Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease
Start: 2006-05-31End: 2006-07-31Target: 80Updated: 2007-12-10
Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Young and Elderly Subjects
CompletedNCT00480818
Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease
Start: 2006-09-30End: 2007-07-31Target: 80Updated: 2007-12-11
Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects
CompletedNCT00519298
Wyeth is now a wholly owned subsidiary of PfizerAdult, Healthy
Start: 2007-10-31End: 2008-03-31Target: 25Updated: 2008-04-22
Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531
CompletedNCT00726115
Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease
Start: 2008-08-31End: 2009-02-28Updated: 2009-07-30
Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered
CompletedNCT00745576
Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease
Start: 2008-10-31End: 2008-12-31Updated: 2010-02-08
Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects
CompletedNCT00906191
Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease
Start: 2009-05-31End: 2009-08-31Updated: 2009-08-26

Phase 2